PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VPCCX vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VPCCX and LLY is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

VPCCX vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard PRIMECAP Core Fund (VPCCX) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%SeptemberOctoberNovemberDecember2025February
334.34%
2,974.44%
VPCCX
LLY

Key characteristics

Sharpe Ratio

VPCCX:

0.35

LLY:

0.69

Sortino Ratio

VPCCX:

0.53

LLY:

1.13

Omega Ratio

VPCCX:

1.08

LLY:

1.15

Calmar Ratio

VPCCX:

0.49

LLY:

0.87

Martin Ratio

VPCCX:

1.31

LLY:

2.00

Ulcer Index

VPCCX:

4.17%

LLY:

10.57%

Daily Std Dev

VPCCX:

15.68%

LLY:

30.85%

Max Drawdown

VPCCX:

-48.32%

LLY:

-68.27%

Current Drawdown

VPCCX:

-5.69%

LLY:

-3.78%

Returns By Period

In the year-to-date period, VPCCX achieves a 4.75% return, which is significantly lower than LLY's 19.46% return. Over the past 10 years, VPCCX has underperformed LLY with an annualized return of 5.83%, while LLY has yielded a comparatively higher 31.78% annualized return.


VPCCX

YTD

4.75%

1M

-0.93%

6M

-3.34%

1Y

4.17%

5Y*

7.48%

10Y*

5.83%

LLY

YTD

19.46%

1M

12.02%

6M

-3.78%

1Y

18.47%

5Y*

49.28%

10Y*

31.78%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VPCCX vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VPCCX
The Risk-Adjusted Performance Rank of VPCCX is 2929
Overall Rank
The Sharpe Ratio Rank of VPCCX is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of VPCCX is 2323
Sortino Ratio Rank
The Omega Ratio Rank of VPCCX is 2626
Omega Ratio Rank
The Calmar Ratio Rank of VPCCX is 4444
Calmar Ratio Rank
The Martin Ratio Rank of VPCCX is 2828
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 6969
Overall Rank
The Sharpe Ratio Rank of LLY is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6464
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6363
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 7878
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VPCCX vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard PRIMECAP Core Fund (VPCCX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VPCCX, currently valued at 0.35, compared to the broader market-1.000.001.002.003.004.000.350.69
The chart of Sortino ratio for VPCCX, currently valued at 0.53, compared to the broader market0.002.004.006.008.0010.000.531.13
The chart of Omega ratio for VPCCX, currently valued at 1.08, compared to the broader market1.002.003.001.081.15
The chart of Calmar ratio for VPCCX, currently valued at 0.49, compared to the broader market0.005.0010.0015.000.490.87
The chart of Martin ratio for VPCCX, currently valued at 1.31, compared to the broader market0.0020.0040.0060.0080.001.312.00
VPCCX
LLY

The current VPCCX Sharpe Ratio is 0.35, which is lower than the LLY Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of VPCCX and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.35
0.69
VPCCX
LLY

Dividends

VPCCX vs. LLY - Dividend Comparison

VPCCX's dividend yield for the trailing twelve months is around 1.03%, more than LLY's 0.59% yield.


TTM20242023202220212020201920182017201620152014
VPCCX
Vanguard PRIMECAP Core Fund
1.03%1.08%1.25%1.34%0.70%1.23%1.39%1.38%1.07%1.25%1.17%1.25%
LLY
Eli Lilly and Company
0.59%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

VPCCX vs. LLY - Drawdown Comparison

The maximum VPCCX drawdown since its inception was -48.32%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for VPCCX and LLY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-5.69%
-3.78%
VPCCX
LLY

Volatility

VPCCX vs. LLY - Volatility Comparison

The current volatility for Vanguard PRIMECAP Core Fund (VPCCX) is 3.78%, while Eli Lilly and Company (LLY) has a volatility of 6.92%. This indicates that VPCCX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
3.78%
6.92%
VPCCX
LLY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab